Skip to content

uniQure QURE Accrued Expenses

Accrued Expenses at other companies

Ultragenyx Pharmaceutical logo
Ultragenyx PharmaceuticalRARE
$17M+408%
Denali Therapeutics Inc. logo
Denali Therapeutics Inc.DNLI
$9.22M+20.4%
CRISPR Therapeutics logo
CRISPR TherapeuticsCRSP
$13.11M
BridgeBio Pharma logo
BridgeBio PharmaBBIO
$39.34M+17.6%
ALN
Alnylam PharmaceuticalsALNY
$946.49M+34.4%
Krystal Biotech, Inc. logo
Krystal Biotech, Inc.KRYS

Other financials

Income statement

See full
Revenue$3.6M+127%
Gross profit$3.3M+144%
Operating income-$45.7M-16.2%
Net income-$53.5M-22.7%
EPS (diluted)-$0.85-3.7%

Balance sheet

See full
Cash & equivalents$140.0M-35.6%
Total debt$63.3M-4.3%
Total equity$149.3M+343%
Total assets$778.7M+28.6%

Cash flow

See full
Operating cash flow-$38.2M+13.3%
CapEx$140.0K+11.1%
Free cash flow-$38.4M+13.2%

Valuation

See full
Market cap$3.09B+78.4%
Enterprise value$3.02B+124%
P/S170.9×+85.1×

Profitability

See full
Gross margin90.6%-2.9pp
Operating margin-1,059.7%+380pp
Net margin-1,154.4%+89.3pp
FCF margin-953.7%+169pp

Returns & leverage

See full
Return on equity-228.2%-11.6pp
Debt / equity0.4×-1.5×
Current ratio10.4×-1.6×

Where this comes from

Reported directly by uniQure in its filing.

Tagged under the XBRL concept us-gaap:AccruedLiabilitiesCurrent.

The official record: uniQure’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about uniQure's accrued expenses.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is uniQure's accrued expenses?
uniQure (QURE) reported accrued expenses of $43.2M in Q1 2026.
How has uniQure's accrued expenses changed year-over-year?
uniQure's accrued expenses increased by 58.0% year-over-year, from $27.34M to $43.2M.
What is the long-term trend for uniQure's accrued expenses?
Over 5 years (2020 to 2025), uniQure's accrued expenses has grown at a 18.0% compound annual growth rate (CAGR), from $18.04M to $41.29M.
What does accrued expenses mean?
Expenses incurred but not yet paid or invoiced — interest accruals, tax accruals, warranty reserves, and other timing differences.